Aptevo Therapeutics Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Aptevo Therapeutics Inc. (APVO) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $1.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-26
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $1.25M.
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2016 was $460.00K, a 88.20% decline from fiscal 2015.
- Aptevo Therapeutics Inc. effective income tax rate reconciliation, tax credit, amount for fiscal 2015 was $3.90M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|
| 2025-12-31 | $1.25M 10-K · filed 2026-03-26 |
| 2016-12-31 | $460.00K 10-K · filed 2017-03-31 |
| 2015-12-31 | $3.90M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |